Skip to content

Clinical trials

Triple Negative Breast Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Country / region: South Korea Clear all

72 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20123
20131
20142
20152
20163
20174
20189
20199
20206
20218
20227
20232
20246
20259

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting19
Active, not recruiting14
Terminated8
Unknown status5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC8
AstraZeneca7
Hoffmann-La Roche7
Novartis Pharmaceuticals6
Gilead Sciences5
AbbVie4
Eli Lilly and Company3
Samsung Medical Center3
Yonsei University3
National Cancer Center, Korea2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms72
Breast Neoplasms25
Carcinoma, Non-Small-Cell Lung14
Ovarian Neoplasms12
Endometrial Neoplasms11
Squamous Cell Carcinoma of Head and Neck11
Stomach Neoplasms11
Neoplasm Metastasis10
Colorectal Neoplasms8
Neoplasms8

Trials

Showing 26 to 50 of 72. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.